SCHEMBL2653207

SCHEMBL2653207

CCOC(=O)c1ccc(CC(C)CSc2cc(C)c(-c3ccc(C(F)(F)F)cc3)c(C)c2)s1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HSP90AA1 P07900 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
PPARD Q03181 17/20 0.41
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PPARA Q07869 7/20 0.39
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655724 0.92 MAPT (0.37) MEN1MAPTKMT2AKDM4EHSP90AA1
SCHEMBL2655360 0.89 PPARD (0.43) PPARDPPARAPPARG
SCHEMBL2654045 0.83 MAPT (0.43) MEN1MAPTKMT2AKDM4EHSP90AA1
SCHEMBL2661440 0.82 PPARD (0.37) MAPTKDM4EPPARDPPARAPPARG
SCHEMBL2656159 0.80 GRIA4 (0.37) MAPTPPARDPPARA
SCHEMBL2656753 0.80 PPARD (0.42) PPARDPPARAPPARG
SCHEMBL2666531 0.78 MEN1 (0.47) MEN1MAPTKMT2AKDM4EHSP90AA1
SCHEMBL2653203 0.78 MEN1 (0.43) MEN1MAPTKMT2AKDM4EHSP90AA1
SCHEMBL2662349 0.78 MEN1 (0.43) MEN1MAPTKMT2AKDM4EHSP90AA1
SCHEMBL2660004 0.77 PPARD (0.46) MEN1MAPTKMT2AKDM4EHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856090-A2 SUBSTITUTED THIOPHENE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-11-21 EP disclosed
WO-2006086488-A2 SUBSTITUTED THIOPHENE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2006-08-17 WO disclosed